SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $77,000 | -29.4% | 14,200 | -2.7% | 0.00% | -33.3% |
| Q1 2021 | $109,000 | -29.2% | 14,600 | +2.8% | 0.00% | -25.0% |
| Q4 2020 | $154,000 | +20.3% | 14,200 | -2.1% | 0.00% | -33.3% |
| Q3 2020 | $128,000 | -15.2% | 14,500 | +2.1% | 0.01% | -25.0% |
| Q2 2020 | $151,000 | +1272.7% | 14,200 | +1094.3% | 0.01% | +700.0% |
| Q2 2019 | $11,000 | +37.5% | 1,189 | +58.5% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | +60.0% | 750 | +53.1% | 0.00% | – |
| Q4 2017 | $5,000 | -54.5% | 490 | -34.7% | 0.00% | -100.0% |
| Q3 2017 | $11,000 | -42.1% | 750 | -37.8% | 0.00% | -50.0% |
| Q2 2017 | $19,000 | – | 1,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |